statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for ACLX
 DateFirmActionFromTo Mar 2022SVB LeerinkInitiates Coverage OnOutperform Mar 2022B of A SecuritiesInitiates Coverage OnBuy
 View More Analyst Ratings for ACLX...

Analyst Expectations For Arcellx's Future

Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD), today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma...

Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma...

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today...

Arcellx Provides First Quarter 2024 Financial Results

Arcellx to Participate in Two Upcoming Investor Conferences

Arcellx (NASDAQ:ACLX - Get Free Report)s stock had its "outperform" rating reiterated by equities research analysts at Scotiabank in a report released on Thursday, Stock Target Advisor...

Arcellx (NASDAQ:ACLX) Stock Rating Reaffirmed by Scotiabank

Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Rami Elghandour sold 23,086 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $67.09, for a...

Rami Elghandour Sells 23,086 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock

Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Arcellx, Inc. (NASDAQ:ACLX  Get Free Report) insider Christopher Heery sold 5,450 shares of the firms stock in a transaction on Tuesday, March 26th. The shares were sold at an average...

Insider Selling: Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $376,649.50 in Stock

Insider Sell: Arcellx Inc's Chief Medical Officer Christopher Heery Disposes of 46,815 Shares

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

Watchers	226
52-Wk Low	$30.74
52-Wk High	$75.10

Volume	439,340.00
52-Wk High	$75.10
52-Wk Low	$30.74

ACLX Arcellx Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community